DECISION TECHNOLOGIES LIMITED

Financial Health Assessment: DECISION TECHNOLOGIES LIMITED

1. Financial Health Score: B

Explanation: The company exhibits strong structural health and excellent regulatory compliance, bolstered by the robust corporate "immune system" of its parent company, Mony Group (MoneySuperMarket). However, the detailed financial blood work—such as profitability, liquidity, and cash reserves—is obscured by its subsidiary status, preventing a complete independent assessment of its internal vitals.

2. Key Vital Signs

• Corporate Pulse (Ownership & Control): The company's pulse is strong and synchronized with a larger corporate body. It is majority-owned by Moneysupermarket.Com Financial Group Limited and Mony Group Financial Limited, with a minority stake held by Bgf Gp Limited and Business Growth Fund Plc. This indicates that the company is well-capitalized and supported by a major corporate parent, though it lacks operational independence.
• Regulatory Temperature (Filing Compliance): The company's regulatory temperature is completely normal. Accounts are filed up to date (with the next due in late 2027) and the confirmation statement is not overdue. There are no signs of administrative fever or regulatory distress.
• Capital Blood Count (Share Capital): The share capital sits at a mere £47. While this might look like a symptom of anemia, it is actually a common structural feature in wholly-owned subsidiaries. The financial "blood supply" is typically maintained through intercompany loans from the parent rather than share capital, meaning the company relies on the group's circulatory system for funding.
• Business Metabolism (Industry & Operations): Operating in SIC code 62090 (Other information technology service activities), the company has a high metabolism, operating in the fast-paced tech and digital comparison sector. Its website indicates it creates websites and apps for home comms and entertainment packages—perfectly aligning with the MoneySuperMarket group's core operations.

3. Diagnosis

The patient is a healthy, functioning organ within a larger corporate body. As an "Audit Exemption Subsidiary," its individual financial vitals (such as turnover, profit, and loss) are consolidated into the parent group's accounts, which is why specific financial metrics are currently unavailable for independent diagnosis.

The reliance on corporate parents for direction and funding means the company does not suffer from the typical cash flow maladies that independent SMEs face, but it is entirely dependent on the group's overall health. The recent resignation of a secretary (Shazadi Stinton, Feb 2026) is a minor administrative change that poses no threat to the company's health. There are no symptoms of distress, insolvency, or director disqualifications.

4. Recommendations

• Monitor Intercompany Health: Ensure that intercompany funding arrangements (the financial lifeblood from the parent) are properly documented, reviewed annually, and conducted at arm's length to maintain financial wellness and tax compliance.
• Maintain Compliance Hygiene: Continue filing accounts and confirmation statements on time to prevent any regulatory fever or penalties that could reflect poorly on the parent group.
• Review Capital Structure: While £47 share capital is normal for this structure, ensure that the company maintains sufficient intercompany loan facilities or working capital to cover its operational liabilities, keeping the business in robust health without requiring emergency group bailouts.